Dr. Larry C. Evans, D.O.
Gastroenterology (Gastroenterology Physician)
2770 Cortez Ave
Idaho Falls, ID 83404
Who else practices at this address →
Bonneville County includes primary care (1% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- At Still University of Health Sciences, College of Osteo Med, Kirksville (2001)
- Years since graduation
- 25
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 280
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2001Medical school: At Still University of Health Sciences, College of Osteo Med, Kirksville
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
ID license O-0468
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Mountain View Hospital Idaho Falls, ID
- Idaho Falls Community Hospital, LLC Idaho Falls, ID
Medical groups
- Mountain View Hospital LLC (276 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 280
- Services billed
- 625
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Biopsy of large bowel using a flexible endoscope | 86 | 85 |
| Established patient office or other outpatient visit, 30-39 minutes | 76 | 60 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 61 | 61 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 61 | 60 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 30 | 30 |
| New patient office or other outpatient visit, 45-59 minutes | 25 | 25 |
| Insertion of guide wire with dilation of esophagus using a flexible endoscope | 22 | 21 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 18 | 13 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 17 | 17 |
| Established patient office or other outpatient visit, 20-29 minutes | 16 | 16 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Omeprazole Other prescribers in Idaho Falls, ID | 180 |
| Sod Sulf-Potass Sulf-Mag Sulf (sodium, potassium,mag sulfates) Other prescribers in Idaho Falls, ID | 153 |
| Linzess (linaclotide) Other prescribers in Idaho Falls, ID | 32 |
| Famotidine Other prescribers in Idaho Falls, ID | 25 |
| Pantoprazole Sodium Other prescribers in Idaho Falls, ID | 25 |
| Ondansetron Hcl Other prescribers in Idaho Falls, ID | 23 |
| Dicyclomine Hcl Other prescribers in Idaho Falls, ID | 20 |
| Gavilyte-G (peg3350/sod sulf,bicarb,cl/kcl) Other prescribers in Idaho Falls, ID | 19 |
| Budesonide Dr (budesonide) Other prescribers in Idaho Falls, ID | 17 |
| Peg-3350 And Electrolytes (peg3350/sod sulf,bicarb,cl/kcl) Other prescribers in Idaho Falls, ID | 16 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 13 companies reported 36 payments worth $582 in total to this clinician.
| AbbVie Inc. | $208 |
|---|---|
| Aimmune Therapeutics, Inc. | $57.01 |
| Ardelyx, Inc. | $44.35 |
| Genzyme Corporation | $40.69 |
| Takeda Pharmaceuticals U.S.A., Inc. | $38.97 |
| Orphalan Inc | $37.22 |
| Janssen Biotech, Inc. | $29.02 |
| Pfizer Inc. | $28.27 |
| Food and Beverage | $582 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 4 industry-funded studies in 2025, from 3 companies. The companies reported $128,656 in research payments for these studies, mostly to the institutions running them.
- A Phase 3, Multi-Center, Multi-National, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of CC-93538 in Adult and Adolescent Subjects with Active Eosinophilic Esophagitis.
Celgene Corporation - A Multi-Center, Multi-National, Randomized, Double-Blind, Placebo-Controlled Induction and Long-term Controlled Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Subjects with Active Eosino…
Celgene Corporation - EoE-201
Phathom Pharmaceuticals, Inc. - A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.
AbbVie Inc. · Active, not recruiting · NCT06063967
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.